Literature DB >> 3094042

Plasma and tissue levels of flecainide in rats.

D Piovan, R Padrini, M Furlanut, R Moretto, M Ferrari.   

Abstract

The time-courses of flecainide plasma and tissue levels were studied in Wistar male rats after i.v. administration (4 mg/Kg). Drug assay in plasma and tissue was performed with a specific and accurate HPLC technique. The final half lives in plasma and tissues were about 4 hours, except in the brain where the half life value was 9.8 hours. The mean tissue/plasma (T/P) ratios in myocardial, kidney, liver, skeletal and muscle tissues were 9.11, 13.8, 14.37, 6.31 respectively, while in the brain the T/P ratio rose progressively over the sampling time to 10.0. These data suggest that flecainide may accumulate in the central nervous system during prolonged treatment. Flecainide levels in adipose tissue were very low. Finally, there was an early "bulge" in the concentration curve, possibly reflecting enterohepatic circulation or non-linear elimination kinetics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094042     DOI: 10.1016/0031-6989(86)90115-3

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  3 in total

1.  Flecainide plasma concentrations correlated to inhibition of a bundle of Kent.

Authors:  E Casiglia; C Martines; R Moretto; D Piovan
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

2.  Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.

Authors:  Niels Voigt; Nadiia Rozmaritsa; Anne Trausch; Thomasz Zimniak; Torsten Christ; Erich Wettwer; Klaus Matschke; Dobromir Dobrev; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-17       Impact factor: 3.000

3.  Flecainide distribution in human tissues.

Authors:  R Latini; A Cavalli; A P Maggioni; A Volpi
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.